Marpe Technologies Receives FDA Breakthrough Device Designation for its Revolutionary Dermatology Screening System

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

CAESAREA, ISRAEL / ACCESSWIRE / July 31, 2023 / Marpe Technologies, a leading innovator in dermatology screening solutions, is thrilled to announce that its groundbreaking full-body Dermatology Screening System has been granted Breakthrough Device designation by the Food and Drug Administration (FDA). The prestigious designation comes after the FDA reviewed and approved Marpe’s combination product and proposed indication for use.

The Marpe System is designed to acquire and analyze total body images to support the identification of malignant and pre-malignant lesions, with a particular focus on melanoma in adult patients. The system records all lesions and acquires dermoscopic views on suspicious lesions, providing clinicians with comprehensive information for review, comparison to previous scans, and referral to biopsy for diagnosis. The system also stores all images for future comparisons.

“We are truly honored and excited to receive FDA’s Breakthrough Device designation,” said Tovi Bechar, CEO of Marpe Technologies. “This recognition is a testament to the tireless efforts of our dedicated team and the potential impact of our innovative Dermatology Screening System in advancing the field of dermatology.”

The Breakthrough Device designation signifies the FDA’s acknowledgment of Marpe’s technology as a significant advancement in the early diagnosis and treatment of skin conditions. This recognition will facilitate a streamlined regulatory review process, enabling Marpe to expedite the development and commercialization of its revolutionary product.

“We believe that Marpe’s Dermatology Screening System has the potential to revolutionize the way dermatological conditions are detected and treated,” added Yaakov Navon, CTO of Marpe Technologies. “With the FDA’s support, we are one step closer to making this cutting-edge technology accessible to patients and healthcare providers worldwide.”

Marpe Technologies extends its gratitude to the FDA for this significant achievement and looks forward to continuing its mission of delivering innovative solutions that improve patient outcomes and transform dermatology care.

For more information about Marpe Technologies and its Dermatology Screening System, please visit MarpeTech.com.

About Marpe Technologies:

Marpe Technologies is a leading medical technology company dedicated to revolutionizing dermatology care. Its state-of-the-art Dermatology Screening System leverages Technology Aided Dermatology (TAD) and AI-CAD based solutions to enhance early detection and prevention of skin conditions, focusing on the identification of malignant melanoma and suspicious nevus/moles.

Contact:

Anat Kaphan
Marpe Media Relations
Email: media@marpetech.com

SOURCE: Marpe Technologies

View source version on accesswire.com:
https://www.accesswire.com/771096/Marpe-Technologies-Receives-FDA-Breakthrough-Device-Designation-for-its-Revolutionary-Dermatology-Screening-System

Staff

Recent Posts

Strategikon Pharma Secures Growth Loan to Expand Sales and Client Support Teams Amid Rising Demand

Company-friendly debt solution will support expansion of the rapidly-growing innovative software company SAN FRANCISCO, June…

4 hours ago

lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics

SAN DIEGO, June 10, 2025 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), aligned with its commitments…

10 hours ago

Applied Medical Technology, Inc. Unveils Redesigned Mobile App Aligned with Recent Website Refresh

BRECKSVILLE, Ohio., June 10, 2025 /PRNewswire/ -- Applied Medical Technology, Inc. (AMT), a leader in innovative…

10 hours ago

NCPDP Foundation Awards $200,000 Grant to CARIN Alliance for Consumer-Facing Real-Time Pharmacy Benefit Check Project

SCOTTSDALE, Ariz., June 10, 2025 /PRNewswire/ -- The NCPDP Foundation is pleased to announce the approval…

10 hours ago

CSD Charts a New Course for Career Growth with Launch of Career Rewards

Milestone recognition, mentorship, and advancement opportunities come together as part of the Career Compass initiative…

10 hours ago

The YMCA of Metropolitan Chicago Names Adam M. Alonso as Next President and CEO

Veteran nonprofit executive and youth development champion Adam M. Alonso named President and CEO of…

10 hours ago